Physician profile

Randall Crim

Colon & Rectal Surgery · Irving, TX

NPI 1063443703

$2,275.86

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$93.71

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $1,376.36 2019-2021
Micro-Tech Endoscopy USA, INC. $348.06 2019-2020
Stryker Corporation $161.07 2020
Abbvie INC. $125.76 2022-2024
Sirtex Medical INC $116.34 2019
Conmed Corporation $45.45 2019
Access Pro Medical, LLC $42.93 2022
Takeda Pharmaceuticals U.S.A., INC. $24.72 2023 Entyvio
Ethicon US, LLC $19.67 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $15.50 2024 Xifaxan

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Randall Crim

$2,275.86

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/139263/randall-crim

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.